News
Vinay Prasad leaves FDA apparently due to backlash from the agency's handling of potential deaths related to Sarepta's ...
Disclosure: None. This article is originally published at Insider Monkey.
Trial data showed the drug dramatically reduced cancer progression risk in certain patients, supporting Celcuity’s plans to ...
2d
MedPage Today on MSNNew FDA Drug Chief: 'Revolving Door' or Reformer?The founder and former CEO of several pharmaceutical companies, Tidmarsh was tapped by FDA Commissioner Marty Makary, MD, MPH ...
Bristol Myers Squibb has appointed Cristian Massacesi, M.D., as Executive Vice President, Chief Medical Officer, and Head of Development.
Roche’s move came against a backdrop of wider industry retreat from gene therapy, with Pfizer pulling its FDA-approved ...
Bristol Myers Squibb has appointed Dr Cristian Massacesi as Executive Vice President, Chief Medical Officer and Head of ...
The appointment of a seasoned pharmaceutical executive, George Tidmarsh, to run the FDA’s drug center underscores the ...
Modern Retina provides ophthalmology professionals with the latest advancements, research, and expert insights in retinal ...
A new study offers insights into the relative efficacy of various treatments for alopecia areata (AA), suggesting that deuruxolitinib (Leqselvi; Sun Pharma) at a dosage of 12 mg twice daily for 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results